Publication | Closed Access

Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study

SleepDouble-blind Placebo-controlled StudyPsychoactive DrugFirst-episode SchizophreniaPsychiatryPsychotic DisorderMedicinePsychotropic MedicationPsychopharmacologySchizophreniaNeuropharmacologyMetabolic Side-effectsSocial SciencesPharmacotherapyPharmacologyMelatoninPsychopathology